
### [NCIT:C43584](http://purl.obolibrary.org/obo/NCIT_C43584)
**Label:** Rectosigmoid Adenocarcinoma

**Subclasses:** [NCIT:C43592](http://purl.obolibrary.org/obo/NCIT_C43592) (Rectosigmoid Mucinous Adenocarcinoma), [NCIT:C43593](http://purl.obolibrary.org/obo/NCIT_C43593) (Rectosigmoid Signet Ring Cell Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C2987](http://purl.obolibrary.org/obo/NCIT_C2987) (Diarrhea))) 70.00%
- [NCIT:C100104](http://purl.obolibrary.org/obo/NCIT_C100104) (Sign or Symptom) 63.09%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36655](http://purl.obolibrary.org/obo/NCIT_C36655) (Polysomy 3))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36654](http://purl.obolibrary.org/obo/NCIT_C36654) (CDH1 Gene Inactivation))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36651](http://purl.obolibrary.org/obo/NCIT_C36651) (FGFR2 Gene Amplification))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36650](http://purl.obolibrary.org/obo/NCIT_C36650) (FGFR1 Gene Amplification))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36648](http://purl.obolibrary.org/obo/NCIT_C36648) (der(1;16)(q10;p10)))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36647](http://purl.obolibrary.org/obo/NCIT_C36647) (i(1)(q10)))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36646](http://purl.obolibrary.org/obo/NCIT_C36646) (Loss of Chromosome 11q ATM Gene Locus))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36645](http://purl.obolibrary.org/obo/NCIT_C36645) (Loss of Chromosome 3p FHIT Gene Locus))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36644](http://purl.obolibrary.org/obo/NCIT_C36644) (Loss of E-cadherin Expression))) 60.82%
- [NCIT:C5034](http://purl.obolibrary.org/obo/NCIT_C5034) (Disturbance in Bowel Function) and (not ([NCIT:C36643](http://purl.obolibrary.org/obo/NCIT_C36643) (Cyclin E Protein Overexpression))) 60.82%


